APO2370 Holding

Active Risk: not assessed

Private limited companyfounded 2026incorporated this yearSchutterstraat 4, 2370 Arendonk, BelgiumKBO/BCE: BE 1042.695.362

Summary

APO2370 Holding is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Watch Print / PDF

Signals

1 signal. The signal on the left, the evidence on the right.

+raises risk

Young company

Founded in 2026, under 3 years in business. Failure risk is statistically highest between 2 and 8 years after founding.

KBO · incorporation date

Age against the risk zone

Checked, nothing found (1)

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials

First annual accounts expected by 31-07-2028

The first financial year runs to 31-12-2027. No annual accounts are due yet, so no filing is missing.

Timeline · acts, filings and financial milestones

All 1Gazette 1

2026

22-09

State Gazette act Incorporation

Appointments: Duphar, K Pharma and I Farma · Permanent representatives: DUYTS, Victor, SCHELLEKENS, Katrien Rita Louis and STEEMANS, Isabeau · Founder15 facts ▸

Incorporation, 18-09-2026
Founder, Duphar
Founder, K Pharma
Founder, I Farma
Capital contribution, €340.000
Capital contribution, €340.000
Capital contribution, €340.000
Director appointment, Duphar (non-statutory director)
Permanent representative, DUYTS, Victor (permanent representative)
Director appointment, K Pharma (non-statutory director)
Permanent representative, SCHELLEKENS, Katrien Rita Louis (permanent representative)
Director appointment, I Farma (non-statutory director)
+3 further facts in this act

State Gazette act

Directors · office · real estate

Directors

under verification, no change since 2026

This board is reconstructed from a single act (26363982). A Gazette act generally publishes only CHANGES, not a full roll call, so directors unchanged since then may be missing here. The KBO register holds the complete list of function holders.

Duphar

Non-statutory director · since 22-09-2026 · Limited partnership · perm. rep.: DUYTS, Victor

Current

I Farma

Non-statutory director · since 22-09-2026 · Limited partnership · perm. rep.: STEEMANS, Isabeau

Current

K Pharma

Non-statutory director · since 22-09-2026 · Limited partnership · perm. rep.: SCHELLEKENS, Katrien Rita Louis

Current

22-09-2026 Duphar: Appointed as Non-statutory director

22-09-2026 I Farma: Appointed as Non-statutory director

22-09-2026 K Pharma: Appointed as Non-statutory director

Location & real-estate footprint

Registered office, Arendonk

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Schutterstraat 42370 Arendonk

Ground area

818 m²

Building footprint

229 m²

Volume, LiDAR

1,281 m³

Parcel 13322E0001/00P003, Flanders · tallest building 10.2 m, ±2 floors. Linked by address, not a title deed.

1 parcel

Flanders 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
13322E0001/00P003	Flanders	818 m²	1 · 229 m²	10.2 m · 2 fl.

Linked by address, not proof of ownership

Methodology

via registered seat: 1

1 of 1 parcel with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Articles of association

Who signs

“De vennootschap wordt geldig vertegenwoordigd als volgt: a) indien er slechts één bestuurder is: door de enige bestuurder, alleen handelend voor alle handelingen. b) indien er twee of meer bestuurders benoemd werden: - door elke bestuurder, afzonderlijk handelend, voor zover het handelingen betreft…”

Full text

De vennootschap wordt geldig vertegenwoordigd als volgt: a) indien er slechts één bestuurder is: door de enige bestuurder, alleen handelend voor alle handelingen. b) indien er twee of meer bestuurders benoemd werden: - door elke bestuurder, afzonderlijk handelend, voor zover het handelingen betreft waarvan de waarde of tegenwaarde het bedrag van 5.000,00 euro niet overtreft. Een reeks samenhangende handelingen moet voor deze berekening worden samengeteld. - door minstens twee bestuurders, samen handelend, voor alle andere handelingen. Zij moeten tegenover derden geen bewijs leveren van hun machten. Het bestuursorgaan kan het dagelijks bestuur, alsook de vertegenwoordiging van de vennootschap wat dat bestuur aangaat, opdragen aan één of meer personen, die dan de titel dragen van dagelijks bestuurder. Zij kunnen individueel optreden. De dagelijks bestuurder kan in het kader van dat bestuur bijzondere volmachten verlenen aan iedere lasthebber.

according to the deed of 22-09-2026

Financial year

From 1 January to 31 December

First financial year to 31-12-2027, first annual accounts due by 31-07-2028

according to the deed of 22-09-2026

Annual meeting

Last Friday of May at 19:00

according to the deed of 22-09-2026

Structure & network

Capital and shareholders

Shareholders according to the acts

At incorporation act of 22-09-2026 ↗

Duphar (BE 1042.207.689) 340,000 EUR
K Pharma (BE 1042.353.288) 340,000 EUR
I Farma (BE 1042.208.778) 340,000 EUR

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years

22-09-2026 Incorporation · 10,200 shares

Company data · Crossroads Bank

Identification

Legal formPrivate limited company

Founded18-09-2026

Sources

Crossroads Bank for EnterprisesAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.